Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ROS-responsive drug delivery systems: Harnessing redox biology for targeted therapies.

Colloids and surfaces. B, Biointerfaces·2026

Same author

Development and characterization of barley starch nanoformulation of folic acid using mild alkali hydrolysis technique.

Journal of biomaterials science. Polymer edition·2025

Same author

Formulation, sterilization, and clinical evaluation of microneedles for vaccine and biologic delivery: A review.

International journal of pharmaceutics·2025

Same author

Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road Ahead.

Drug development research·2025

Same author

Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?

Naunyn-Schmiedeberg's archives of pharmacology·2024

Same author

Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices.

Drug delivery and translational research·2024

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Focused Ion Beam Lithography to Etch Nano-architectures into Microelectrodes

Focused Ion Beam Lithography to Etch Nano-architectures into Microelectrodes

Published on: January 19, 2020

Nano-interventions for neurodegenerative disorders.

Clara Fernandes¹, Umangi Soni, Vandana Patravale

¹Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (Autonomous), Matunga, Mumbai 400 019, Maharashtra, India.

Pharmacological Research

|February 16, 2010

Summary

Nanoparticle drug delivery offers a promising strategy for treating central nervous system (CNS) diseases by enabling therapeutic agents to cross the blood-brain barrier. This review explores various nanoparticles for effective CNS treatment.

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Related Experiment Videos

Last Updated: Jun 16, 2026

Focused Ion Beam Lithography to Etch Nano-architectures into Microelectrodes

Focused Ion Beam Lithography to Etch Nano-architectures into Microelectrodes

Published on: January 19, 2020

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Area of Science:

Neuroscience
Nanotechnology
Pharmacology

Background:

Central nervous system (CNS) diseases are increasing due to longer lifespans and demographic shifts.
Neurodegenerative diseases are often multisystemic, complicating treatment approaches.

Purpose of the Study:

To review the applications of nanoparticle-based drug delivery across the blood-brain barrier.
To explore nanoparticle types, pharmacokinetics, targeting, cellular uptake, and toxicity for CNS disorders.

Main Methods:

Literature review of nanoparticle applications in CNS drug delivery.
Analysis of various nanoparticle types (e.g., polymerics, liposomes).
Discussion of pharmacokinetic parameters and targeting strategies.

Main Results:

Nanoparticles demonstrate potential for delivering therapeutics across the blood-brain barrier.
Different nanoparticle formulations exhibit varied pharmacokinetic profiles and targeting efficiencies.
Mechanisms of cellular uptake and potential toxicity require careful consideration.

Conclusions:

Nanotechnology offers innovative solutions for overcoming the blood-brain barrier in CNS disease treatment.
Further research into nanoparticle design, targeting, and safety is crucial for clinical translation.
Understanding cellular interactions and toxicity is essential for developing effective nano-therapeutics for neurological disorders.